【Nakagawa City, Fukuoka Prefecture】Metallo-Balance Test for Cancer and Cognitive (MCI) Risk Assessment with Just 6mL of Blood Draws Begins Reservation at Yoshida Clinic from August

Renatech Corporation (headquartered in Isehara City, Kanagawa Prefecture), which develops health indicators based on trace elements and applies them in society, announces the opening of reservations for its self-developed screening test, the 'Metallo-Balance Test,' which evaluates the risk of cancer and MCI (mild cognitive impairment). Reservations for testing at Yoshida Clinic (Nakagawa City, Fukuoka Prefecture), a partner medical institution, are now open for August to October 2026.

With the establishment of a continuous testing system at this clinic, access to the 'Metallo-Balance Test' in the Nakagawa City area will be stabilized, contributing as a practical option for local residents' daily health management and pre-disease prevention.

Renatech will continue to work with partner medical institutions nationwide to maintain and expand testing availability, aiming to encourage more people to take interest in their health and reflect on their daily habits and lifestyle as part of pre-disease prevention.

What is the Metallo-Balance (MB) Test?

The Metallo-Balance Test is a risk screening (triage) test that objectively evaluates the risk of cancer and MCI (mild cognitive impairment) at the time of blood draw by analyzing the concentration balance of 17 trace elements (metal elements) in the blood.

【Features of the Test】

Only one 6mL blood draw: Blood is safely collected under the proper management of medical institutions. The test takes only about 15 minutes, minimizing physical burden and ensuring safety.

Site-specific 'Cancer Risk Test': With a single blood draw, cancer risk is evaluated by site (6 sites for men, 9 for women) and scored on a four-tier scale from A to D. [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, endometrial cancer, ovarian cancer

Comprehensive 'Cognitive Risk Test (MCI Risk Assessment)': Evaluates all types of cognitive impairment, including Alzheimer's, vascular, and Lewy body types.

Proven research achievements and international recognition: Developed through joint research with the Kanagawa Cancer Center and Chiba Cancer Center, supported by a research grant from the Ministry of Economy, Trade and Industry's Go-Tech program. Patented in 9 countries including Japan, with over 100,000 test-takers cumulatively (from April 2019 to March 2026).

Testing Process and Key Pre-Test Notes

※ Due to the need for document mailing procedures, advance registration is required approximately three weeks before the desired test date (by complete reservation system).

Application: Apply via the website or by phone. A complete set of test documents will be delivered to your home about one week before your scheduled appointment.

Test Day (Blood Draw): As the clinic operates on a complete reservation basis, blood draws are conducted smoothly (takes about 15 minutes). Payment is on a post-pay basis, so no on-site payment is required.

Results Notification: Your invoice (payment slip) will be mailed to your home approximately three weeks after blood draw, and your test results will follow about five weeks later.

【Key Pre-Test Notes】

Food and Alcohol: No food after 9 PM the previous day. No alcohol consumption the day before. Hydration: Drink plenty of water to make blood drawing easier.

Medication and Supplements: Over-the-counter medicines and supplements must be discontinued the day before. Prescription medications should be taken as usual.

Test Fees (Private Pay)

This test is a private-pay service not covered by health insurance. Choose from the following plans based on your needs:

Cancer Risk Test: 19,800 JPY (tax included)

Cognitive Risk Test: 19,800 JPY (tax included)

Cancer and Cognitive Risk Test (Combo): 24,200 JPY (tax included)

※ Listed prices are standard rates. ※ Payment will be via 'DSK Postpay,' delivered to your home after blood draw. ※ Some medical institutions may not offer one of the tests.

Eligibility and Important Notes for the Metallo-Balance Test

【Age Eligibility】

Cancer Risk Test: Japanese nationals aged 20 to 80

Cognitive Risk Test: Japanese nationals aged 50 to 80

※ This test was developed based on data from Japanese individuals within the above age ranges. While individuals outside these age groups or foreign nationals may take the test, results will be provided as 'reference values' only. Please understand this in advance.

【Individuals Who Cannot Take the Test】

Pregnant individuals or those within 6 months postpartum

Individuals currently undergoing cancer treatment or within one year of completing treatment

Individuals undergoing dialysis

Individuals with fractures, blood disorders, or immunodeficiency (excluding lipid abnormalities such as high triglycerides)

Individuals in poor health (lack of sleep, after an all-nighter, immediately after intense exercise, under severe stress, or experiencing symptoms such as cold, asthma, shingles, allergic rash, or rhinitis)

Overview of Partner Medical Institution

Testing Hours: Generally Mondays to Saturdays (excluding holidays and clinic closure days)

Medical Institution Name: Yoshida Clinic

Address: 4-53-2 Nakahara, Nakagawa City, Fukuoka 811-1213 🅿️ Parking available 📍MAP

Access: 10-minute walk from JR 'Hakata-Minami Station'

Available Tests: Cancer Risk Test, Cognitive Risk Test

▼ Check Available Dates and Make a Reservation Testing schedules for August to October, as well as the latest schedules from November onward, can be viewed and booked anytime via the web reservation system below.

Metallo-Balance Test Web Reservation: https://metallo-balance.net/entry/

＜Steps to Check Dates and Apply＞

Select 'General Public' (red button) on the URL above

Select the relevant region (Kyushu > Fukuoka Prefecture) under 'Find a Test Site'

Select 'Yoshida Clinic' as the test site to view currently available specific testing dates. ※ Each testing slot has a capacity limit. Registration closes once full, so please understand in advance.

⚠️ Important Request Regarding Testing (Please Read) Please refrain from contacting the medical institution directly: The clinic's front desk or phone line cannot accept applications or inquiries for this test. All questions and applications regarding the test should be directed to Renatech.

For details and applications, please visit:

Metallo-Balance Test Information Site (for test details): https://www.mbkensa.com/

Toll-Free Number: 0120-785-602 (Renatech: Weekdays 9:00–17:00)

▼ Digital Version of Metallo-Balance Test Brochure

d182526-33-53d63cfaf5201a1d65ff5709966fef04.pdf

🏥 Partner medical institutions nationwide are also being recruited! For information on introducing the Metallo-Balance Test, click here

Metallo-Balance Original Character: Metalona-chan

Renatech Corporation is an innovative company developing proprietary technologies in the medical and health fields, as well as environmental fields, aiming for early risk assessment of diseases such as cancer. It has been selected as one of the '300 Outstanding SMEs and Small-Scale Enterprises' by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency, recognizing its high technological capability and social contribution.

Among its offerings, the 'Metallo-Balance Test' analyzes the concentration of 17 trace elements in the blood to assess the risk of cancer